Literature DB >> 28001185

Serum uric acid and its association with hypertension, early nephropathy and chronic kidney disease in type 2 diabetic patients.

Mohamed Fouad1, Hoda Fathy2, Amal Zidan2.   

Abstract

INTRODUCTION: Early detection diabetic nephropathy (DN) is important. Whether serum uric acid (SUA) has a role in the development of DN is not known.
OBJECTIVE: To study the relationship between SUA and hypertension, early nephropathy and progression of chronic kidney disease (CKD) in type 2 diabetes mellitus (T2DM).
METHODS: The total number of the study was 986 participants, according to presence and duration of diabetes were classified into three groups. Group I; including 250 healthy participants. Group II; including 352 with onset of diabetes < 5 years. Group III; including 384, with the onset of diabetes > 5 years. All participants were submitted to complete clinical examination, anthropometric measurements, laboratory investigations, including glycosylated hemoglobin (HbA1C), as well triglycerides to high-density lipoprotein ratios (TG/HDL-C), SUA, urinary albumin/creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR).
RESULTS: SUA, BP, HbA1c, TG/HDL-C ratio, and ACR levels were significantly higher in group III than group I, II and in II than I. eGFR significantly lower in group III than group I, II and in II than I (p < 0.001). Age, BMI, BP, HbA1c, TG/HDL-C, ACR, were positively correlated with SUA, while GFR negatively correlated. SUA at level of > 6.1 mg/dl, > 6.2 mg/dl and > 6.5 mg/dl had a greater sensitivity and specificity for identifying hypertension, early nephropathy and decline eGFR respectively.
CONCLUSION: Even high normal SUA level, was associated with the risk of hypertension, early nephropathy and decline of eGFR. Moreover SUA level may identify the onset of hypertension, early nephropathy and progression of CKD in T2DM.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28001185     DOI: 10.5935/0101-2800.20160065

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  6 in total

Review 1.  Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective.

Authors:  Rui Xue; Dingkun Gui; Liyang Zheng; Ruonan Zhai; Feng Wang; Niansong Wang
Journal:  J Diabetes Res       Date:  2017-03-13       Impact factor: 4.011

2.  Vitamin D and Elevated Serum Uric Acid as Novel Predictors and Prognostic Markers for Type 2 Diabetes Mellitus.

Authors:  Abdulbari Bener; Abdulla O A A Al-Hamaq; Mustafa Öztürk; Ihab Tewfik
Journal:  J Pharm Bioallied Sci       Date:  2019 Apr-Jun

3.  Risk Predictors of High Uric Acid Levels Among Patients with Type-2 Diabetes.

Authors:  Zobeida Eljaaly; Muhammad Mujammami; Shaik Sarfaraz Nawaz; Mohamed Rafiullah; Khalid Siddiqui
Journal:  Diabetes Metab Syndr Obes       Date:  2021-12-24       Impact factor: 3.168

4.  Effectiveness of Early Advanced Glycation End Product Accumulation Testing in the Diagnosis of Diabetes: A Health Risk Factor Analysis Using the Body Mass Index as a Moderator.

Authors:  Yi Zhang; Tian Jiang; Chao Liu; Honglin Hu; Fang Dai; Li Xia; Qiu Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-11       Impact factor: 5.555

5.  Advanced glycation end products and diabetes and other metabolic indicators.

Authors:  Tian Jiang; Yi Zhang; Fang Dai; Chao Liu; Honglin Hu; Qiu Zhang
Journal:  Diabetol Metab Syndr       Date:  2022-07-25       Impact factor: 5.395

6.  Hyperuricaemia is associated with dyslipidemia but not HbA1c among type 2 diabetes mellitus patients in Botswana.

Authors:  Ellen Gobusamang; Naledi G Nyepetsi; Modisa S Motswaledi; Ishmael Kasvosve
Journal:  Afr J Lab Med       Date:  2019-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.